Alternative za pretraživanje:
"eso opens" » "best opens" (Proširi pretraživanje), "era opens" (Proširi pretraživanje), "o opens" (Proširi pretraživanje), "esdo opens" (Proširi pretraživanje), "esao opens" (Proširi pretraživanje), "eso openss" (Proširi pretraživanje)
"eo open" » "neo open" (Proširi pretraživanje), "do open" (Proširi pretraživanje), "ao open" (Proširi pretraživanje), "edo open" (Proširi pretraživanje), "eao open" (Proširi pretraživanje), "eo opens" (Proširi pretraživanje)
"esmo open" » "esmdo open" (Proširi pretraživanje), "esmao open" (Proširi pretraživanje), "esmo opens" (Proširi pretraživanje), "esto open" (Proširi pretraživanje), "ecmo open" (Proširi pretraživanje)
"o open" » "do open" (Proširi pretraživanje), "ao open" (Proširi pretraživanje), "o opens" (Proširi pretraživanje)
Prikaz rezultata 141 – 160 od 958 za pretraživanje '(((((("eo open") OR ("eso opens"))) OR ("esmo open"))) OR ("o open"))', vrijeme pretraživanja: 0,75s Detaljiziraj rezultate
Cancer and the arts: La Madonna dei Tumori, Ravenna, Italy
Applying the ESMO-Magnitude of Clinical Benefit Scale in real life

Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
Immune-related response criteria: light and shadows

I-SPY 2: optimising cancer drug development in the 21st century
Where do they come from? A call for complete transparency regarding the origin of human tissues in research

TAS-102 and the quest for predictive biomarkers
Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid

Admission of critically ill patients with cancer to the ICU: many uncertainties remain
Reply to ‘Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’

The integrating nutritional therapy in oncology (INTO) project: rationale, structure and preliminary results
Cancer and the arts: how often do doctors only see what they want to see? Or: the case of an ‘epidemic of breast cancer among famous artists’

Correction: Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
ESMO Leaders Generation Programme: an alumni insight

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
Controversies in oncology: surgery for small cell lung cancer? It’s time to rethink the case

Alati za pretraživanje: Preuzmi RSS sažetak — Pošalji ovo pretraživanje e-poštom — Spremi pretraživanje